Wellcome Infectious Disease Clinical Trial Award 2026: Funding Up to £8 Million for Global Health Impact @Unknown

Overview

The Infectious Disease Clinical Trial Award offers researchers a significant opportunity to secure funding for large-scale, high-impact clinical trials aimed at improving the effectiveness of pharmaceutical interventions in low- and middle-income countries.

Eligibility

• Research teams based in Africa, South Asia, or South-East Asia (excluding mainland China).
• At least one lead applicant and one co-applicant from eligible regions.
• Team must have at least 50% of its members located in these regions, with a maximum of eight applicants plus collaborators.
• Affiliation with eligible institutions like universities, research institutes, healthcare organizations, or non-profits.

Benefits

• Funding amount ranging from £1 million to £8 million per project.
• Duration of funding support is 3 to 5 years.
• Approximately 8–12 grants available.
• Comprehensive coverage of costs such as staff salaries, equipment, clinical trial expenses, travel, public engagement, and data management.

How to Apply

Applications must be submitted via the Wellcome Funding platform.

Deadline

The application deadline is 2 June 2026 (15:00 BST).